Ahmed H. Sadik
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Author Correction: Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progression.
Journal: Nature communications
Published: October 17, 2025
Cross-species comparison reveals therapeutic vulnerabilities halting glioblastoma progression.
Journal: Nature communications
Published: March 05, 2025
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: October 08, 2023
Spatial probabilistic mapping of metabolite ensembles in mass spectrometry imaging.
Journal: Nature communications
Published: November 07, 2021
ID3 promotes homologous recombination via non-transcriptional and transcriptional mechanisms and its loss confers sensitivity to PARP inhibition.
Journal: Nucleic acids research
Published: July 19, 2021
Tryptophan metabolism is inversely regulated in the tumor and blood of patients with glioblastoma.
Journal: Theranostics
Published: March 20, 2021
Hypoxia Routes Tryptophan Homeostasis Towards Increased Tryptamine Production.
Journal: Frontiers in immunology
Published: August 01, 2020
Functional screening identifies aryl hydrocarbon receptor as suppressor of lung cancer metastasis.
Journal: Oncogenesis
Published: February 03, 2020
IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression.
Journal: Cell
Published: December 16, 2019
Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas.
Journal: Nature communications
Published: November 25, 2019
Hypoxia Inducible Factor 1α Inhibits the Expression of Immunosuppressive Tryptophan-2,3-Dioxygenase in Glioblastoma.
Journal: Frontiers in immunology
Published: September 04, 2019
Last Updated: 09/26/2026